Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial

BACKGROUND: Major Depressive Disorder (MDD) can lead to adverse cardiovascular outcomes in patients with chronic kidney disease (CKD). Although one of the proposed mechanisms is heightened platelet activation, effects of MDD and its treatment with a selective serotonin reuptake inhibitor (SSRI) on p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Nishank, Wan, Fei, Kothari, Monica, Adelodun, Anuoluwapo, Ware, Jerry, Sarode, Ravi, Hedayati, S. Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819518/
https://www.ncbi.nlm.nih.gov/pubmed/31664940
http://dx.doi.org/10.1186/s12882-019-1576-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819518/
https://www.ncbi.nlm.nih.gov/pubmed/31664940
http://dx.doi.org/10.1186/s12882-019-1576-7

Ejemplares similares